ArticleBMC plant biology2026
The RcMYB308-RcEGL1 module regulates cyanidin accumulation by targeting the RcF3'H promoter in pink roses.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated RNA-Seq and DAP-Seq Analyses Identify a DntMYB1-Centered Regulatory Module Controlling Purple Flower Formation in Nobile-TypePlants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundRose accounts for over one-third of the global cut flower industry, with pink varieties dominating the market. However, research on the mechanism for pink petal formation in rose is still insufficient.
resultsTo elucidate the molecular mechanism of rose petal pigmentation, we performed metabolome and transcriptomics analyses of two rose progenies derived from the hybridization of Rosa chinensis var. Spontanea and 'Old Blush', which exhibit light pink (LP) and dark pink (DP) flowers, respectively. Metabolome analysis identified pelargonidin derivatives as major anthocyanins in DP, while cyanidin 3-O-coumaroylglucoside-5-O-glucoside (Cy3cG5G), as a key anthocyanins, was exclusively detected at S3 in DP, perfectly matching the formation timing of the dark pink phenotype. Transcriptomics data revealed differentially expressed genes involved in flavonoid and anthocyanin biosynthesis, corresponding to varying anthocyanin levels in petals, between the two roses. In addition, integrated analysis uncovered molecular networks regulating petal pigmentation and identified transcription factors RcMYB308 and RcMYB1b as key players in the accumulation of anthocyanins and flavonol derivatives. Here, yeast two-hybrid (Y2H) and bimolecular fluorescence complementation (BIFC) assays demonstrated that these proteins form MYB-bHLH complexes with RcEGL1 to activate anthocyanin biosynthesis genes. The dual-luciferase (Dual-LUC) assays demonstrated that RcMYB308 activated RcF3'H, thereby bolstering anthocyanin accumulation, while RcMYB1b could bind to the RcF3'H promoter and exert a negative regulatory effect on RcF3'H. The overexpression and silencing of RcMYB308 in petals revealed that it facilitated anthocyanin accumulation by specifically regulating RcF3'H-mediated cyanidin synthesis, resulting in dark pink pigmentation.
conclusionCollectively, our analysis of two pink rose progenies reveals that the RcMYB308-RcEGL1 module regulates petal color divergence during development via direct targeting of the RcF3'H promoter. These findings clarify key elements of the gene-metabolism network regulating rose petal coloration and provide a theoretical basis for rose flower color genetic improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.